References
- Andersen A. R., Christiansen J. S., Andersen J. K., Kreiner S., Deckert T. Diabetic nephropathy in Type 1 (insulin‐dependent) diabetes: an epidemiological study. Diabetologia 1983; 25: 496–501
- Borch‐johnsen K., Andersen P. K., Deckert T. The effect of proteinuria on relative mortality in Type 1 (insulin‐dependent) diabetes mellitus. Diabetologia 1985; 28: 590–596
- Jensen T., Borch‐johnsen K., Kofoed‐enevoldsen A., Deckert T. Coronary heart disease in young Type 1 (insulin‐dependent) diabetic patients with and without diabetic nephropathy: incidence and risk‐factors. Diabetologia 1987; 30: 144–148
- Luttun A., Tjwa M., Moons L. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti‐Flt1. Nature Medicine 2002; 8: 831–840
- Maglione D., Guerriero V., Viglietto G., Dellibovi P., Persico M. G. Isolation of A Human Placenta Cdna Coding for A Protein Related to the Vascular‐Permeability Factor. Proc. Natl. Acad. Sci. USA 1991; 88: 9267–9271
- Heeschen C., Dimmeler S., Fichtlscherer S. Prognostic value of placental growth factor in patients with acute chest pain. Journal of the American Medical Association 2004; 291: 435–441
- Tarnow L., Cambien F., Rossing P. Insertion/deletion polymorphism in the angiotensin‐I‐converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995; 38: 798–803
- Tarnow L., Cambien F., Rossing P. Lack of relationship between an insertion/deletion polymorphism in the angiotensin‐I‐converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995; 44: 489–494
- Parving H. ‐. H., østerby R., Ritz E. Diabetic nephropathy. The Kidney 7, B. M Brenner. WB Saunders, Philadelphia 2003; 1777–1818
- Feldt‐rasmussen B., Dinesen B., Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985; 45: 539–544
- Bröchner‐mortensen J., Rödbro P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 1976; 36: 35–45
- Rose G. A., Blackburn H. Cardiovascular survey methods.1, , et al. World Health Organization, Geneva 1968; 1–188
- Astrup A. S., Tarnow L., Rossing P., Pietraszek L., Riis hansen P., Parving H. ‐. H. Improved prognosis in type 1 diabetes patients with nephropathy – a prospective follow‐up study. Kidney International, 2005 in press
- Gaede P., Vedel P., Larsen N., Jensen G. V. H., Parving H., Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383–393
- Pfeffer M. A., Swedberg K., Granger C. P. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM‐overall programme. Lancet 2003; 362: 759–766
- Aiello L. P., Avery R. L., Arrigg P. G. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480–1487
- Hovind P., Tarnow L., østergaard P., Parving H. ‐. H. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney International 2000; 57: S56–S61
- Jensen T., Stender S., Deckert T. Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulin‐dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 1988; 31: 142–145
- Hansen T. K., Tarnow L., Thiel S. Association between mannose‐binding lectin and vascular complications in Type 1 diabetes. Diabetes 2004; 53: 1570–1576
- Saraheimo M. T., Forsblom C., Hansen T. K. Increased levels of mannan‐binding lectin (MBL) in Type 1 diabetic patients with incipient and overt nephropathy. Diabetologia 2005; 48: 198–202